William Blair adds five stocks to November conviction list
William Blair updated its November Analyst Conviction List, adding five stocks and removing four. New additions include American Public Education (APEI), EQT (EQT), Healthcare Services Group (HCSG), Matador Resources (MTDR), and MiniMed Group. HCSG, trading at $24.52, is noted for strong returns and undervaluation. Removed stocks include Amazon (AMZN), Cushman & Wakefield (CWK), Devon Energy (DVN), and Remitly (RELY).
How this was made
The 30-second read
Why it matters
The additions provide fresh analyst endorsement, which can drive short‑term buying pressure, especially for the newly added small‑cap names.
Market read
The list updates may influence trading activity in the highlighted stocks, with HCSG also delivering an earnings beat.
What to watch
Potential downside if broader market sentiment turns negative or sector rotation occurs.
Background
William Blair publishes a monthly analyst conviction list, adding five stocks and removing four.
Ticker impact
Added to William Blair's November conviction list as a high-conviction pick for the next six months.
likely upward pressure as traders add to positions
Analyst conviction lists often trigger buying activity, especially for small‑cap stocks.
Added to the November conviction list, signaling strong analyst confidence.
moderate upside as analysts' endorsement attracts buyers
EQT is a mid‑cap energy firm; analyst picks can move the stock modestly.
Added to the conviction list and reported Q3 2026 earnings that beat expectations.
upward pressure from earnings beat and new analyst coverage
Both earnings surprise and conviction list inclusion provide fresh, material information.
Added to the November conviction list as a high‑conviction pick.
likely slight upside as investors respond to the pick
Conviction list additions often generate short‑term buying pressure.
Market effects
Highlights analyst confidence in education, energy, healthcare, and oil & gas sectors.
U.S. small‑ and mid‑cap equities may see modest inflows.
Limited to U.S. markets; no direct global macro effect.
Counterpoint
Conviction list picks can be overhyped; price may already be priced in.
Key entities
- Research FirmWilliam Blair
Provider of the analyst conviction list.
